Cited by 164Protein Tyrosine PhosphatasesMetabolism, Diabetes, and CancerProtein Kinase Regulation and GTPase Signaling

The COOH-terminal Tyrosine Phosphorylation Sites on IRS-1 Bind SHP-2 and Negatively Regulate Insulin Signaling

Open access
Myers, Martin G., Mendez, Raul, Shi, Ping, Pierce, Jacalyn H., Rhoads, Robert, White, Morris F.·1998·Journal of Biological Chemistry

Abstract

Activation of tyrosine kinases by numerous growth factor and cytokine receptors leads to tyrosine phosphorylation of the insulin receptor substrate (IRS)-proteins. Tyrosine-phosphorylated motifs on the IRS proteins bind to the SH2 domains in proteins that mediate downstream signals, including phosphatidylinositol 3'-kinase, GRB-2, and SHP-2. We investigated the function of the two SHP-2 binding COOH-terminal tyrosines of IRS-1 by replacing them with phenylalanine (IRS-1(FCT)). IRS-1(FCT) failed to bind SHP-2 or mediate its tyrosine phosphorylation during insulin stimulation. Although several reports suggest a critical role for SHP-2 in insulin stimulated mitogen-activated protein kinase activation and cell proliferation, IRS-1(FCT) mediated these effects normally in 32D cells. Indeed, IRS-1(FCT) exhibited increased tyrosine phosphorylation, phosphatidylinositol 3'-kinase binding and activation of protein synthesis in response to insulin. These results suggest that SHP-2 attentuates the phosphorylation and downstream signal transmission of IRS-1 and that the interaction of IRS-1 and SHP-2 is an important regulatory event which attenuates insulin metabolic responses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.273.41.26908

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The IGF1R/ERBB2/3 signaling pathway may respond to the suppressed ERK and AKT signaling after KRAS (G12C) inhibitor treatment and favor the change to epithelial cell types.

    “The IGF1R/ERBB2/3 signaling pathway may respond to the suppressed ERK and AKT signaling after KRAS (G12C) inhibitor treatment and favor the change to epithelial cell types (Fig. 5).”
  • This changed cell type is more sensitive to co-inhibition by SHP2 and SOS1.

    “This changed cell type is more sensitive to co-inhibition by SHP2 and SOS1 [130–135].”
  • High basal ERBB2/3 associated with epithelial gene signatures was observed in KRAS (G12C) cell lines and human lung cancers.

    “High basal ERBB2/3 associated with epithelial gene signatures was observed in KRAS (G12C) cell lines and human lung cancers.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 56 · Cited by 164

Research works printed but not linked: 4

  1. Freeman, R. M., Jr., Plutzky, J., and Neel, B. G. (1992) Proc. Natl. Acad. Sci. U .S .A. 89, 11239 -11243
  2. Yamauchi, K., Milarski, K. L., Saltiel, A. R., and Pessin, J. E. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 664 -668
  3. Ruderman, N., Kapeller, R., White, M. F., and Cantley, L. C. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 1411-1415
  4. Towbin, H., Staehelin, T., and Gordon, G. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350 -4354

Authors
Myers, M. G., Mendez, R., Shi, P., Pierce, J. H., Rhoads, R., & White, M. F.
Affiliations
  • Joslin Diabetes Center (US)
  • National Institutes of Health (US)
  • Louisiana State University (US)
Corresponding author
Myers, Martin G.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1998-10
Volume
273
Issue
41
Pages
26908-26914
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1981072221
Cited by
164
References
56
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 2 · 2016: 5 · 2015: 2 · 2014: 4 · 2013: 6 · 2012: 6
FWCI
4.19
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 43808, R01DK043808)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
IRS-1, SHP2, tyrosine phosphorylation, insulin signaling, SH2 domain binding, phosphatidylinositol 3-kinase, mitogen-activated protein kinase, cell proliferation, protein synthesis
MeSH terms
Animals, Cell Division, Enzyme Activation, Cricetinae, Humans, Insulin, Phosphoproteins, Phosphorylation, Protein Binding, Tyrosine, Signal Transduction, CHO Cells, Protein Tyrosine Phosphatases, Calcium-Calmodulin-Dependent Protein Kinases, Phosphatidylinositol 3-Kinases, Intracellular Signaling Peptides and Proteins, Rats, Protein Tyrosine Phosphatase, Non-Receptor Type 6, Protein Tyrosine Phosphatase, Non-Receptor Type 11, Insulin Receptor Substrate Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review